MAITREYA

Maitreya Medicare Limited

Listed company · ISIN INE0PLQ01011 · NSE SM · FV ₹10
Last price
₹117
+2.98%today
What this company does

Maitreya Medicare Limited is a listed company. It booked ₹21 cr of revenue in its latest half year (H2 FY26) and kept -11.5% of sales as profit.

25out of 100
Equitytale Health Score
Fragile

Healthier than 25% of listed companies we score, on the 4 of 6 measures we could read for it. Each measure is ranked against the 2,334–2,885 companies that reported it.

Measures financial condition, not whether to buy. Learn what this score means · How this is calculated

Price momentum
neutral
RSI (14)
48

At close. Not part of the score.

Profitability & returns4

How much profit it earns on the money it employs

Balance sheet12

How much it owes, and whether earnings cover the interest

Valuation28

What today's price implies, against our models or its peers

Governance & risk100

How much of the promoters' stake is pledged, and how much they hold · highest in its sector on what we could measure

Not measurable for this company: cash quality, growth & consistency. Those pillars are left out of the score rather than counted as zero.

Is this company doing well?
not investment advice
Some things to watch
Strengths
✓ Promoters hold 73%
✓ No promoter shares pledged
Watch-outs
! Currently loss-making
! Thin -11.5% net margin
! Low -27.8% return on equity
! Carries high debt (D/E 1.3)

What if I invest in MAITREYA?

Set a growth rate and see what a monthly SIP would add up to. Your assumption, our arithmetic.

You would put in
₹12.00 lakh
120 instalments
At 5% a year, it would become
₹15.50 lakh

The slider starts at 5%, taken from a generic assumption, not this company's history. That is history, not a forecast — this is your assumption, and the figure above is arithmetic on it. Returns are not steady year to year, and a real holding would not grow in a straight line. We do not publish price targets or predict returns.

Key ratios · latest half year + price
₹117▲ +2.98%
latest close · 2026-10-01
52-wk low ₹10347 sessions so far52-wk high ₹142
Is it cheap or expensive?
What you pay for the profits, book value and cash flow. Higher isn't automatically worse — it can signal faster growth.
P/B ratio4.55High
Below bookModerateHigh
How good is the business?
How much profit it earns from its money and its sales.
Return on equity-27.8%Loss
WeakFairStrong ▸15%
Return on capital-5.6%Loss
WeakFairStrong
Net margin-11.5%Loss
ThinDecentStrong
EBITDA margin-6.9%Loss
ThinDecentHealthy
Is it financially safe?
How much it owes, and whether it can comfortably cover it.
Debt to equity1.32High
LowModerateHigh ▸1
Interest cover-1.4×Risky
RiskyOkayStrong ▸5×
Current ratio1.47Healthy
Tight ◂1HealthyAmple
More figures
Market cap
₹80 cr
Book value
₹26
EPS
₹-3.59
latest half year
Net debt
₹14 cr
owes more than its cash
Enterprise value
₹94 cr
EBITDA
₹-3 cr
annualised
EBIT
₹-3 cr
annualised
Operating margin
-6.9%
Return on assets
-7.1%
Earnings yield
—
P/S
1.88
Sales / share
₹62.4
Tax rate
—
Face value
₹10
Shares
0.7 cr
Working capital
₹7 cr
Current assets
₹23 cr
Current liabilities
₹16 cr
Delivery %
70.3%
Strong / safeFairWeak / riskyValuation — a level, not good/badBands are general rules of thumb, not advice.

P/E, ROE, ROCE and margins are annualised from the latest half year; per-share and balance-sheet ratios use the most recent balance sheet on file · prices as of 2026-10-01.

Worth vs price · from the exchange filings
not investment advice
Hard to value confidentlyLow confidence
The company's latest annual profit was negative, so we won't call it cheap off older profits.
Models span ₹115–₹115, midpoint ₹115

An educational model from the company's own filings, every assumption shown — not investment advice or a price target. Prices can stay above or below any model for years.

P&L · H2 FY26 (consolidated)
Revenue from Operations₹21 cr
Other Income₹75.7 L
Total Income₹22 cr
Cost of Materials₹3 cr
Purchases of Stock-in-Trade₹2 cr
Inventory Change (±)₹0.71 L
Employee Benefit Expense₹3 cr
Finance Costs₹1 cr
Other Expenses₹15 cr
Total Expenses₹24 cr
Profit before Tax₹-3 cr
Tax Expense₹-9.3 L
Net Profit₹-2 cr
Net margin on total income-11.1%
Where the money goes · H2 FY26
% of total spend
Materials + stock-in-trade₹5 cr19.8%
Employee benefit expense₹3 cr11.8%
Finance costs₹1 cr4.3%
Other expenses₹16 cr64.1%
Total income ₹22 cr

The company made a net loss of ₹2 cr this half year — income covered only ₹90 of every ₹100 it spent on costs and tax.

Half-yearly results · consolidated (₹ cr)
MetricH1 FY26H2 FY26
Revenue24 cr21 cr
Total income24 cr22 cr
Expenses24 cr24 cr
Profit before tax5.1 L-3 cr
Tax8.7 L-9.3 L
Net profit (owners' share)-3.6 L-2 cr
Net margin (owners' share, on revenue)-0.2%-11.5%
EPS (₹)-0.05-3.59
Balance sheet & cash flow · as of Mar 2026
High debt
Total assets
₹68 cr
Shareholder equity
₹17 cr
parent shareholders
Total debt
₹23 cr
Cash
₹9 cr
Who owns it · 2026-03-31
No pledge
Promoter
73.1%
Public
26.9%
What shareholders were asked to approve

A company cannot decide everything on its own. Things like a top executive’s pay, issuing new shares, or re-appointing a director have to be put to the people who own the company, and they vote — one vote per share. So whoever owns the most shares has the most say.

Yearly shareholder meeting · 21 Sep 2026
See the official result
1
1 - To receive, consider and adopt the Audited Financial Statement of the Company for the financial year ended March 31, 2026 together with the reports of the Board of Directors and Auditors thereonand in this regard, pass the following resolutions as Ordinary Resolution
Backed by 100% of shareholders other than promotersneeded 50%
40,800 votes for, 0 against
2
2 - Re-appointment of Mr. Vimalkumar Natverlal Patel (DIN: 08458999) as a Whole time Director who retires by rotation and being eligible offers himself for re-appointment.
Promoters had a personal stake in this
Backed by 100% of shareholders other than promotersneeded 50%
40,800 votes for, 0 against

Every vote count above is taken from the result the company filed with the stock exchange, certified by an independent counter. To work out what would have happened without the promoters, we simply remove their votes and re-apply the same legal bar the proposal had to clear. Nothing here is an estimate or an opinion.

Who controls this company, and what it pays them

Most Indian companies are controlled by a family or group — the promoters. The exchange requires them to be listed by name, including members who own no shares at all, and requires the company to disclose any business it does with them.

The promoter group — 3 named members
owning 73.1% between them · as of 2026-03-31
Narendra Singh Tanwar47.02%
Pranav Rohitbhai Thaker15.66%
Vimalkumar Natverlal Patel10.43%

Names and holdings from the company’s shareholding pattern filed with the exchange; transactions from the related-party note in its annual report. Every figure is as filed — these are legal, disclosed dealings, and what to make of them is your call.

Money it raised, and what it did with it

When a company raises money from investors, it has to say up front what the money is for. The rules then make it report, every three months until the money is gone, how much of each of those things it has actually paid for — so a promise made while asking for the money can be checked afterwards.

₹15 cr raised in Nov 2023 by selling shares to the public

As of Mar 2026, the company says it has spent 100% of what it set aside.

Making Investment through Equity in the subsidiary named ‘Maitreya Hospital Private Limited’ for setting up Hospital at Valsad, Gujarat
100%
of what was set aside
Redemption of part of issued Non-Convertible Redeemable
96%
of what was set aside
Funding the working capital requirements of the company
100%
of what was set aside
General Corporate Expenses
100%
of what was set aside

The rupee amounts in this company’s own breakdown don’t add up to the amount it says it raised — a common filing slip, where a table meant to be read in lakhs is entered as whole rupees. Rather than guess which is right, we show only the percentages, which are unaffected.

Every figure above is taken from the statement the company files with the stock exchange each quarter, for as long as money it has raised remains unspent. The only thing we work out is how much of each stated purpose has been paid for — one number divided by another from the same filing. Whether a plan that changed was a good change is not something a filing can tell you. See the filing

How the stock has moved · adjusted for splits & bonuses
Data from primary exchange filings · analysis tool, not investment advice.